|
Erythromycin EthylsuccinateDrug - Erythromycin Ethylsuccinate The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Erythromycin Ethylsuccinate
Strength -
EQ 400MG BASE/5ML
Applicant -
NASKA
New Drug Application (NDA) Number -
062674
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 10, 1987
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics
Erythromycin Ethylsuccinate
Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral
Pediamycin Eq 100mg Base/2.5ml Suspension/drops; Oral E.E.S. 200 Eq 200mg Base/5ml Suspension; Oral E.E.S. 400 Eq 400mg Base/5ml Suspension; Oral E-mycin E Eq 200mg Base/5ml Suspension; Oral E-mycin E Eq 400mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral NewDrugInformation |